A Phase Ib Multi-Cohort Trial Of Mk-3475 (Pembrolizumab) In Subjects With Hematologic Malignancies
Posted Date: Mar 16, 2016
- Investigator: Trisha Wise-Draper
- Specialties: Hematology/Oncology, Oncology, Cancer
- Type of Study: Drug
This is a research study to test an investigational drug, pembrolizumab, which has been approved for use in certain types of adult melanoma and lung cancer however it has not been approved in any other cancers.
To Be Eligible To Participate Patients Must Have Cancer Of The Blood, Bone Marrow, Or Lymph Nodes.
Mk3475-013, Hematology, Cancer, Phase I, Keynote
For More Information:
Uc Cancer Institute